Company profilePharmaceutical#1090 of 1,318 in Pakistan✓ No DRAP alerts

Calgan Phyto Pharma Pvt. Ltd.

Pharmaceutical company · 2 brands · 3 molecules

Ranked #26 of 35 companies in Fever/Flu/Cough

2 registered products 3 pharmaceutical brands 3 distinct molecules 0 DRAP alerts

Company overview

2
registered products
3
pharmaceutical brands
3
distinct molecules
2
therapeutic classes
0
DRAP alerts

Calgan Phyto Pharma Pvt. Ltd. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 2 product registrations across 3 distinct molecules. Its portfolio is concentrated in Fever/Flu/Cough and Pain Management. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Calgan

2 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Pain Management 1

Top molecules by brand count

Therapeutic classes

Fever/Flu/Cough · 1Pain Management · 1

Conditions treated

Expectorant · 1Topical · 1

Price band (DRAP official ceilings)

Registered products priced by source
Servaid2 products · Rs 195 – Rs 300
Median across source: Rs 247.5

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Martin Dow Marker Limited2 shared molecules
SEARLE PAKISTAN (PVT.) LTD.2 shared molecules
CHAS. A. MENDOZA2 shared molecules
Albro Pharmaceuticals2 shared molecules
FRIENDS PHARMA (PVT) LTD2 shared molecules
MARVI LABORATORIES2 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Martin Dow Marker Limited holds 101 molecules not in this portfolio
000 I.UAlprazolamAlteplaseAmlodipineApixabanArtemether
SEARLE PAKISTAN (PVT.) LTD. holds 237 molecules not in this portfolio
AcetazolamideAdalimumabAlprazolamAmilorideAminophyllineAmitriptyline
CHAS. A. MENDOZA holds 28 molecules not in this portfolio
Ammonium ChlorideAmmonium Chloride Containing Cough ExpectorantArtemetherAscorbic AcidAzithromycinCalcium Pantothenate

Get the full profile for Calgan

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.